Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Kim M. Hirshfield"'
Autor:
Elan Gorshein, Kant Matsuda, Gregory Riedlinger, Levi Sokol, Lorna Rodriguez-Rodriguez, Firas Eladoumikdachi, Miral Grandhi, Shridar Ganesan, Deborah L. Toppmeyer, Lindsay Potdevin, Kathleen Toomey, Kim M. Hirshfield, Nancy Chan
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 931-937 (2021)
Metaplastic breast cancer (MBC) is a rare and aggressive subtype of breast cancer. Tumor characteristics typically feature estrogen receptor, progesterone receptor, and HER2-negative, triple-negative breast cancer (TNBC), with a poorer prognosis rela
Externí odkaz:
https://doaj.org/article/bdb6ea84938e4385b44989b9ca95f57f
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-8 (2021)
Abstract Background Invasive pleomorphic lobular carcinoma (PLC) of the breast is a subtype of invasive lobular cancer which compromises approximately 1% of all epithelial breast malignancies and is characterized by higher nuclear pleomorphism and po
Externí odkaz:
https://doaj.org/article/b1737555f8504c95b3e1fba3fde77125
Autor:
Aparna Kareddula, Daniel J. Medina, Whitney Petrosky, Sonia Dolfi, Irina Tereshchenko, Kelly Walton, Hana Aviv, Evita Sadimin, Alexandra L. Tabakin, Eric A. Singer, Kim M. Hirshfield
Publikováno v:
Therapeutic Advances in Urology, Vol 13 (2021)
Background: Prostate cancer (PCa) phenotypes vary from indolent to aggressive. Molecular subtyping may be useful in predicting aggressive cancers and directing therapy. One such subtype involving deletions of chromodomain helicase DNA binding protein
Externí odkaz:
https://doaj.org/article/ca950f5f2b464ee8b0c531557af922af
Autor:
Bhavna S. Paratala, Jon H. Chung, Casey B. Williams, Bahar Yilmazel, Whitney Petrosky, Kirstin Williams, Alexa B. Schrock, Laurie M. Gay, Ellen Lee, Sonia C. Dolfi, Kien Pham, Stephanie Lin, Ming Yao, Atul Kulkarni, Frances DiClemente, Chen Liu, Lorna Rodriguez-Rodriguez, Shridar Ganesan, Jeffrey S. Ross, Siraj M. Ali, Brian Leyland-Jones, Kim M. Hirshfield
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Fusions of the gene RET have been described in thyroid and lung cancers. Here, the AUs identify RET gene alterations, including known fusions, novel fusions, and rearrangements in breast cancer (BC) that are involved in the tumorigenic process and sh
Externí odkaz:
https://doaj.org/article/af4ef9c2d18542d6986221a4da000c4e
Autor:
Maureen E. Murphy, Song Liu, Song Yao, Dezheng Huo, Qin Liu, Sonia C. Dolfi, Kim M. Hirshfield, Chi-Chen Hong, Qiang Hu, Andrew F. Olshan, Temidayo O. Ogundiran, Clement Adebamowo, Susan M. Domchek, Katherine L. Nathanson, Barbara Nemesure, Stefan Ambs, William J. Blot, Ye Feng, Esther M. John, Leslie Bernstein, Wei Zheng, Jennifer J. Hu, Regina G. Ziegler, Sarah Nyante, Sue A. Ingles, Michael F. Press, Sandra L. Deming, Jorge L. Rodriguez-Gil, Christopher A. Haiman, Olufunmilayo I. Olopade, Kathryn L. Lunetta, Julie R. Palmer, Christine B. Ambrosone
Publikováno v:
npj Breast Cancer, Vol 3, Iss 1, Pp 1-4 (2017)
Genetics: Variant may increase cancer risk in pre-menopausal black women A gene variant found in people of African descent may increase the risk of breast cancer—but only among pre-menopausal women. In a study of more than 14,000 women of African a
Externí odkaz:
https://doaj.org/article/6cbf07c525e841a38a28b2739e09d08a
Publikováno v:
Future Oncology. 17:2581-2592
Aim: To analyze therapy for metastatic triple-negative breast cancer (mTNBC), factors contributing to survival and costs. Patients & methods: Using 2010–2016 SEER-Medicare data, we identified women (≥65 years) with mTNBC. Results: Of 302 eligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c80ae2e56124b09484cea19753bfeb
https://doi.org/10.2217/fon-2021-0019
https://doi.org/10.2217/fon-2021-0019
Autor:
Kelly Walton, Sonia C. Dolfi, Aparna Kareddula, Eric A. Singer, Hana Aviv, Evita Sadimin, Irina V. Tereshchenko, Kim M Hirshfield, Daniel J. Medina, Whitney Petrosky, Alexandra L. Tabakin
Publikováno v:
Therapeutic Advances in Urology, Vol 13 (2021)
Therapeutic Advances in Urology
Therapeutic Advances in Urology
Background: Prostate cancer (PCa) phenotypes vary from indolent to aggressive. Molecular subtyping may be useful in predicting aggressive cancers and directing therapy. One such subtype involving deletions of chromodomain helicase DNA binding protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a52ee6a18805781200dcafd5f14cd82
https://doaj.org/article/ca950f5f2b464ee8b0c531557af922af
https://doaj.org/article/ca950f5f2b464ee8b0c531557af922af
Autor:
Baichen Xu, Bo Qin, Jennifer Tsui, Elisa V. Bandera, Holly A. Szukis, Chi-Chen Hong, Kim M. Hirshfield, Michelle Doose, Yong Lin, Christine B. Ambrosone, Kitaw Demissie, Adana A.M. Llanos, Cathleen Y. Xing
Publikováno v:
Journal of Oncology
Journal of Oncology, Vol 2019 (2019)
Journal of Oncology, Vol 2019 (2019)
Mammogram-detected breast cancers have a better prognosis than those identified through clinical breast exam (CBE) or through self-detection, primarily because tumors detected by mammography are more likely to be smaller and do not involve regional n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e84a16fbaf7bb0694dbccfb33d355db
https://doi.org/10.1155/2019/3529651
https://doi.org/10.1155/2019/3529651
Autor:
Laurie J Kirstein, Maria Kowzun, Shridar Ganesan, Kim M. Hirshfield, Gregory Riedlinger, Serena Wong, L Rodriguez-Rust, Shicha Kumar, Nancy Chan, Thomas Kearney, Deborah Toppmeyer, Kien Pham, Firas Eladoumikdachi, SA Desai, DM Tang, Mridula George, Lindsay Potdevin, Coral Omene, Chen Liu, S-e Lu
Publikováno v:
Cancer Research. 79:P1-15
Background: The use of neoadjuvant platinum with taxane for triple negative breast cancer (TNBC) has gained increased attention for improving rates of pathologic complete response (pCR). Our prior trial combining carboplatin (CAR) with liposomal doxo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6887206949804eb0059011ad44e79e72
https://doi.org/10.1158/1538-7445.sabcs18-p1-15-14
https://doi.org/10.1158/1538-7445.sabcs18-p1-15-14
Autor:
Sibo eTian, Kim M Hirshfield, Salma K Jabbour, Deborah eToppmeyer, Bruce George Haffty, Atif J Khan, Sharad eGoyal
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Multi-modality cancer treatments that include chemotherapy, radiation therapy, and targeted agents are highly effective therapies. Their use, especially in combination, is limited by the risk of significant cardiac toxicity. The current paradigm for
Externí odkaz:
https://doaj.org/article/161bd310749643db8a9367ff70ff85fa